OBMP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products...

Stats
Today's Volume	58 992.00
Average Volume	8 379.00
Market Cap	0.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2020-09-24	Chilcott, Iii Thomas E.	Buy	0
2020-06-05	Ruxin Michael I	Buy	0
2020-05-07	Head Jonathan Frederick	Buy	166 667	Shares of Common Stock
2019-04-24	Holcomb Robert Neal	Buy	3 000 000	Employee Stock Option (right to buy)
2019-04-24	Hoverman Daniel S.	Buy	3 000 000	Employee Stock Option (right to buy)

INSIDER POWER
0.00
Last 25 transactions
Buy: 69 901 401 \| Sell: 14 397 245

Theralink Technologies, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Theralink Technologies, Financials

Annual	2021
Revenue:	$505 604
Gross Profit:	$388 148 (76.77 %)
EPS:	$-0.00124

Q1	2022
Revenue:	$78 975.00
Gross Profit:	$35 410.00 (44.84 %)
EPS:	$-0.000283

Q4	2021
Revenue:	$90 575.00
Gross Profit:	$72 417.00 (79.95 %)
EPS:	$-0.000286

Q1	2021
Revenue:	$9 790.00
Gross Profit:	$8 187.00 (83.63 %)
EPS:	$-0.000285

Financial Reports:

No articles found.

Theralink Technologies,

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.